|
PUT
|
$17,000
|
2.3K
|
Q2 2025
Added 4.55%
|
|
|
CALL
|
$130,000
|
11.1K
|
Q2 2025
Reduced 93.86%
|
|
|
CALL
|
$4.64 Million
|
95.1K
|
Q2 2025
Added 366.18%
|
|
|
CALL
|
$0
|
100
|
Q2 2025
Reduced 98.68%
|
|
|
CALL
|
$1.24 Million
|
13.6K
|
Q2 2025
Added 24.77%
|
|
|
PUT
|
$191,000
|
2.1K
|
Q2 2025
Added 10.53%
|
|
Acadia Healthcare Company In
|
CALL
|
$2.87 Million
|
127K
|
Q2 2025
Added 77.31%
|
|
Acadia Healthcare Company In
|
PUT
|
$40,000
|
1.8K
|
Q2 2025
Reduced 93.81%
|
|
Achieve Life Sciences Inc
|
CALL
|
$2,000
|
1K
|
Q2 2025
Added 900.0%
|
|
Achieve Life Sciences Inc
|
PUT
|
$4,000
|
1.9K
|
Q2 2025
New holding
|
|
|
CALL
|
$5.31 Million
|
247K
|
Q2 2025
Reduced 24.53%
|
|
|
PUT
|
$1.94 Million
|
90.1K
|
Q2 2025
Reduced 68.31%
|
|
American Coastal Ins Corp
|
CALL
|
$260,000
|
23.4K
|
Q2 2025
Reduced 79.55%
|
|
American Coastal Ins Corp
|
PUT
|
$31,000
|
2.8K
|
Q2 2025
Reduced 81.46%
|
|
|
CALL
|
$114,000
|
2.5K
|
Q2 2025
Reduced 26.47%
|
|
|
CALL
|
$578,000
|
8.3K
|
Q2 2025
Reduced 56.08%
|
|
|
PUT
|
$1.22 Million
|
17.5K
|
Q2 2025
Added 90.22%
|
|
|
CALL
|
$144,000
|
2.2K
|
Q2 2025
Reduced 69.86%
|
|
|
PUT
|
$190,000
|
2.9K
|
Q2 2025
Added 625.0%
|
|
|
CALL
|
$1.63 Million
|
14.4K
|
Q2 2025
Reduced 36.28%
|
|
|
PUT
|
$180,000
|
1.6K
|
Q2 2025
Reduced 75.0%
|
|
|
CALL
|
$766,000
|
29.6K
|
Q2 2025
Reduced 47.7%
|
|
|
PUT
|
$4.25 Million
|
164K
|
Q2 2025
Reduced 22.89%
|
|
Acres Commercial Realty Corp
|
CALL
|
$1,000
|
100
|
Q2 2025
Reduced 75.0%
|
|
Ares Coml Real Estate Corp
|
CALL
|
$22,000
|
4.8K
|
Q2 2025
Added 166.67%
|
|
Ares Coml Real Estate Corp
|
PUT
|
$62,000
|
13K
|
Q2 2025
Reduced 0.76%
|
|
|
CALL
|
$5,000
|
3.7K
|
Q2 2025
Reduced 13.95%
|
|
|
CALL
|
$3,000
|
100
|
Q2 2025
New holding
|
|
|
PUT
|
$3,000
|
100
|
Q1 2025
New holding
|
|
|
CALL
|
$1.95 Million
|
121K
|
Q2 2025
Reduced 23.93%
|
|
|
PUT
|
$167,000
|
10.3K
|
Q2 2025
Reduced 58.47%
|
|
Acurx Pharmaceuticals Inc
|
CALL
|
$0
|
8.6K
|
Q2 2025
New holding
|
|
Adaptimmune Therapeutics PLC
|
CALL
|
$2,000
|
11.2K
|
Q2 2025
Reduced 0.88%
|
|
|
CALL
|
$4.6 Million
|
63K
|
Q2 2025
Reduced 8.03%
|
|
|
PUT
|
$803,000
|
11K
|
Q2 2025
Reduced 1.79%
|
|
|
CALL
|
$19,000
|
7.1K
|
Q2 2025
Added 1675.0%
|
|
|
PUT
|
$88,000
|
32.9K
|
Q2 2025
Added 16350.0%
|
|
|
CALL
|
$7,000
|
500
|
Q2 2025
Reduced 98.07%
|
|
|
CALL
|
$2.53 Million
|
139K
|
Q2 2025
Added 0.36%
|
|
|
PUT
|
$1.1 Million
|
60.3K
|
Q2 2025
Added 6.35%
|
|
|
CALL
|
$159,000
|
8.2K
|
Q2 2025
Reduced 77.09%
|
|
|
PUT
|
$180,000
|
9.3K
|
Q2 2025
Reduced 48.62%
|
|
Automatic Data Processing In
|
PUT
|
$7.52 Million
|
24.4K
|
Q2 2025
Reduced 34.76%
|
|
Adaptive Biotechnologies Cor
|
CALL
|
$383,000
|
32.9K
|
Q2 2025
Added 498.18%
|
|
Adaptive Biotechnologies Cor
|
PUT
|
$18,000
|
1.6K
|
Q2 2025
Reduced 30.43%
|
|
|
CALL
|
$11,000
|
1.4K
|
Q2 2025
Reduced 87.04%
|
|
|
PUT
|
$202,000
|
23.9K
|
Q2 2025
Reduced 76.82%
|
|
|
CALL
|
$6,000
|
700
|
Q2 2025
Reduced 98.19%
|
|
|
PUT
|
$7,000
|
800
|
Q2 2025
Reduced 55.56%
|
|
|
CALL
|
$57,000
|
500
|
Q2 2025
Added 150.0%
|
|